[1]柴广睿,刘姝,陈晓隆.核苷酸结合寡聚化结构域样受体蛋白3（NLRP3）炎症体在眼科疾病中的研究进展[J].眼科新进展,2018,38(9):892-897.[doi:10.13389/j.cnki.rao.2018.0211]
　CHAI Guang-Rui,LIU Shu,CHEN Xiao-Long.The progress of NLRP3 inflammasome in ophthalmic diseases[J].Recent Advances in Ophthalmology,2018,38(9):892-897.[doi:10.13389/j.cnki.rao.2018.0211]
点击复制

核苷酸结合寡聚化结构域样受体蛋白3（NLRP3）炎症体在眼科疾病中的研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
38卷
期数:
2018年9期
页码:
892-897
栏目:
文献综述
出版日期:
2018-09-05

文章信息/Info

Title:
The progress of NLRP3 inflammasome in ophthalmic diseases
作者:
柴广睿; 刘姝; 陈晓隆
110004　辽宁省沈阳市，中国医科大学附属盛京医院眼科（柴广睿，陈晓隆）；110001　辽宁省沈阳市，中国医科大学附属第一医院老年病科（刘姝）
Author(s):
CHAI Guang-Rui; LIU Shu; CHEN Xiao-Long
Department of Ophthalmology，Shengjing Hospital of China Medical University（CHAI Guang-Rui，CHEN Xiao-Long），Shenyang 110004，Liaoning Province，China；The First Affiliated Hospital of China Medical University（LIU Shu），Shenyang 110001，Liaoning Province，China
关键词:
NLRP3炎症体; 免疫学; 眼科疾病
Keywords:
nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome; immunology; ophthalmic diseases
分类号:
R77
DOI:
10.13389/j.cnki.rao.2018.0211
文献标志码:
A
摘要:
多种疾病的发生发展均与慢性低度炎症反应有关，其中免疫异常起重要作用。核苷酸结合寡聚化结构域样受体蛋白3（nucleotide-binding oligomerization domain-like receptor protein 3，NLRP3）炎症体作为固有免疫系统的重要组成成分，已被证实在糖尿病、冠状动脉粥样硬化性心脏病、风湿免疫疾病及肿瘤等多种疾病中发挥重要作用。NLRP3炎症体可被多种代谢信号激活，进而引起caspase-1的活化，最终导致细胞释放IL-1β和IL-18，诱发炎症级联反应，引发组织损伤。近来多项研究表明，NLRP3炎症体可能成为多种疾病新的治疗靶点。本文将对NLRP3炎症体的活化与调控机制及其在年龄相关性黄斑变性、角膜炎、葡萄膜炎、青光眼、干眼症、糖尿病视网膜病变及缺血再灌注损伤等眼科疾病中的研究进展及相关治疗前景进行综述。
Abstract:
Chronic low-grade inflammation has been proven to be involved in the occurrence and development of many diseases,and the immune abnormity plays an important role.As an important part of innate immune system,nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome plays a prominent role in diabetes,coronary diseases,rheumatic immune diseases and tumors.Once stimulated by many metabolicsignals,NLRP3 inflammasome can activate caspase-1 and further lead to the release of interleukin-1 β(IL-1β) and interleukin-18(IL-18).This may initiate a cascade of inflammation and cause tissue damage.Plenty of recent researches have conclusively proven NLRP3 inflammasome to be a new therapy target for many diseases.In this paper,we will make a review for the activating pathway and mechanism of NLRP3 and its role in age-related macular degeneration,keratitis,uveitis,glaucoma,xerophthalmia,diabetic retinopathy and retinal ischemia/reperfusion injury ect.The related therapeutic potentials are also summarized.

参考文献/References:

［1］　ALVES B C，SILVA T R，SPRITZER P M.Sedentary lifestyle and high-carbohydrate intake are associated with low-grade chronic inflammation in post-menopause：a cross-sectional study［J］.Rev Bras Ginecol Obstet，2016，38（7）：317-324.
［2］　HOFFMAN H M，MUELLER J L，BROIDE D H，WANDERER A A，KOLODNER R D.Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome［J］.Nat Genet，2001，29（3）：301-305.
［3］　MARTINON F，BURNS K，TSCHOPP J.The inflammasome：a molecular platform triggering activation of inflammatory caspases and processing of pro IL-beta［J］.Mol cell，2002，10（2）：417-426.
［4］　PETRILLI V，DOSTERT C，MURUVE D A，TSCHOPP J.The inflammasome：a danger sensing complex triggering innate immunity［J］.Curr Opin Immunol，2007，19（6）：615-622.
［5］　MAEDLER K，SCHUMANN D M，SAUTER N，ELLINGSGAARD H，BOSCO D，BAERTSCHIGER R，et al.Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets［J］.Diabetes，2006，55（10）：2713-2722.
［6］　KOTAS M E，JURCZAK M J，ANNICELLI C，GILLUM M P，CLINE G W，SHULMAN G I，et al.Role of caspase-1 in regulation of triglyceride metabolism［J］.P Natl Acad Sci USA，2013，110（12）：4810-4815.
［7］　YANG J，ZHAO Y F，ZHANG P，LI Y，YANG Y，ZHU J，et al.Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis：role in pulmonary inflammation following LPS［J］.Cell Death Dis，2016，7（9）：e2363.
［8］　KAYAGAKIN，WARMING S，LAMKANFI M，VANDE WALLE L，LOUIE S，DONG J，et al.Non-canonical inflammasome activation targets caspase-11［J］.Nature，2011，479（7371）：117-121.
［9］　LIU X，ZHANG Z B，RUAN J，PAN Y，MAGUPALLI V G，WU H，et al.Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores［J］.Nature，2016，535（7610）：153-158.
［10］　DOSTERT C，LUDIQS K，GUARDA G.Innate and adaptive effects of inflammasomes on T cell responses［J］.Curr Opin Immunol，2013，25（3）：359-365.
［11］　SCHMID-BURGK J L，GAIDT M M，SCHMID T，EBERT T S，BARTOK E，HORNUNG V.Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells［J］.Eur J Immunol，2015，45（10）：2911-2917.
［12］　RUHLS，BROZ P.Caspase-11 activates a canonical NLRP3 inflammasome by promoting K（+） efflux［J］.Eur J Immunol， 2015，45（10）：2927-2936.
［13］　ZHONG Z，UMEMURA A，SANCHEZ-LOPEZ E，LIANG S，SHALAPOUR S，WONG J，et al.NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria［J］.Cell，2016，164（5）：896-910.
［14］　ZHANG L，XIE L X.The relationship between autophagy and ocular diseases［J］.Chin J Ophthalmol，2016，52（5）：391-395.
张璐，谢立信.细胞自噬与眼部疾病发生的关系［J］.中华眼科杂志，2016，52（5）：391-395.
［15］　CAMELO S.Potential Sources and Roles of Adaptive Immunity in age-related macular degeneration：shall we rename AMD into autoimmune macular disease［J］?Autoimmune diseases，2014，2014：532487.
［16］　TARALLO V，HIRANO Y，GELFAND B D，DRIDI S，KERUR N，KIM Y，et al.DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88［J］.Cell，2012，149（4）：847-859.
［17］　WANG Y，HANUS J W，ABU-ASAB M S，SHEN D，OGILVY A，OU J，et al.NLRP3 upregulation in retinal pigment epithelium in age-related macular degeneration［J］.Int J Mol Sci，2016，17（1）：516-522.
［18］　DOYLE S L，CAMPBELL M，OZAKI E，SALOMON R G，MORI A，KENNA P F，et al.NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components［J］.Nat Med，2012，18（5）：791-798.
［19］　BRANDSTETTER C，HOLZ F G，KROHNE T U.Complement component C5a primes retinal pigment epithelial cells for inflammasome activation by bipofuscin-mediated photooxidative damage［J］.J Biol Chem，2015，290（52）：31189-31198.
［20］　BRANDSTETTER C，PATT J，HOLZ F G，KROHNE T U.Inflammasome priming increases retinal pigment epithelial cell susceptibility to lipofuscin phototoxicity by changing the cell death mechanism from apoptosis to pyroptosis［J］.J Photoch Photobio B，2016，161（8）：177-183.
［21］　MOHRLK，HOFFMANN A V，BRANDSTETTER C，HOLZ F G，KROHNE T U.Effects of inflammasome activation on secretion of inflammatory cytokines and vascular endothelial growth factor by retinal pigment epithelial cells［J］.Invest Ophthalmol Vis Sci，2015，56（11）：6404-6413.
［22］　SHI G，CHEN S，WANDU W S，OGBEIFUN O，NUGENT L F，MAMINISHKIS A，et al.Inflammasomes induced by 7-ketocholesterol and other stimuli in RPE and in bone marrow-derived cells differ markedly in their production of IL-1beta and IL-18［J］.Invest Ophthalmol Vis Sci，2015，56（3）：1658-1664.
［23］　KAUPPINEN A，NISKANEN H，SUURONEN T，KINNUNEN K，SALMINEN A，KAARNIRANTA K.Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells--implications for age-related macular degeneration （AMD）［J］.Immunol Lett，2012，147（1-2）：29-33.
［24］　MARNEROS A G.VEGF-A and the NLRP3 Inflammasome in age-related macular degeneration［J］.Adv Exp Med Biol，2016，854：79-85.
［25］　LIU R T，GAO J，CAO S，SANDHU N，CUI J Z，CHOU C L，et al.Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo：implications for inflammasome activation in age-related macular degeneration［J］.Invest Ophth Vis Sci，2013，54（3）：2225-2237.
［26］　CRUZ-GUILLOTY F，SAEED A M，DUFFORT S，CANO M，EBRAHIMI K B，BALLMICK A，et al.T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration［J］.PLoS One，2014，9（2）:e88201.
［27］　TSENG W A，THEIN T，KINNUNEN K，LASHKARI K，GREGORY M S，D’AMORE P A，et al.NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization：implications for age-related macular degeneration［J］.Invest Ophthalmol Vis Sci，2013，54（1）：110-120.
［28］　KAARNIRANTA K，SINHA D，BLASIAK J，KAUPPINEN A，VEREB Z，SALMINE A，et al.Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration［J］.Autophagy，2013，9（7）：973-984.
［29］　ZHAO T，GAO J，VAN J，TO E，WANG A，CAO S，et al.Age-related increases in amyloid beta and membrane attack complex：evidence of inflammasome activation in the rodent eye［J］.J Neuroinflammation，2015，12：121.
［30］　CAMPBELL M，DOYLE S L.An eye on the future of inflammasomes and drug development in AMD［J］.J Mol Med（Berl），2013，91（9）：1059-1070.
［31］　KERUR N，HIRANO Y，TARALLO V，FOWLER B J，BASTOS-CARVALHO A，YASUMA T，et al.TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy［J］.Invest Ophthalmol Vis Sci，2013，54（12）：7395-7401.
［32］　KARTHIKEYAN R S，LEAL S M JR，PRAJNA N V，DHARMALINGAM K，GEISER D M，PEARLMAN，et al.Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or fusarium［J］.J Infect Dis，2011，204（6）：942-950.
［33］　KARTHIKEYAN R S，PRIVA J L，LEAL SM J R，TOSKA J，RIETSCH A，PRAJNA V，et al.Host response and bacterial virulence factor expression in Pseudomonas aeruginosa and Streptococcus pneumoniae corneal ulcers［J］.PLoS One，2013，8（6）：e64867.
［34］　KARMAKAR M，KATSNELSOM M，MALAK H A，GREENE N G，HOWELL S J，HISE A G，et al.Neutrophil IL-1beta processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux［J］.J Immunol，2015，194（4）：1763-1775.
［35］　GIMENEZ F，BHELA S，DOGRA P，HARVEV L，VARANASI S K，JAGGI U，et al.The inflammasome NLRP3 plays a protective role against a viral immunopathological lesion［J］.J Leukoc Biol，2016，99（5）：647-657.
［36］　LIANG L，TAN X，ZHOU Q，TIAN Y，KIJLSTRA A，YANG P.TLR3 and TLR4 But not TLR2 are involved in vogt-koyanagi-harada disease by triggering proinflammatory cytokines production through promoting the production of mitochondrial reactive oxygen species［J］.Curr Mol Med，2015，15（6）：529-542.
［37］　LIANG L，TAN X，ZHOU Q，ZHU Y，TIAN Y，YU H，et al.IL-1beta triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behcet’s disease［J］.Invest Ophthalmol Vis Sci，2013，54（1）：402-414.
［38］　GONZALEZ-BENITEZ J F，JUARE-VERDAYES M A，RODRIQUEZ-MARTINEZ S，CANCINO-DIAZ M E，GARCIA-VAZQUEZ F，CANCINO-DIAZ J C.The NALP3/Cryopyrin-inflammasome complex is expressed in LPS-induced ocular inflammation［J］.Mediators Inflamm，2008，2008：614345.
［39］　ROSENZWEIG H L，WOODS A，CLOWERS J S，PLANCK S R，ROSENBAUM J T.The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis［J］.Inflamm Res，2012，61（3）：225-231.
［40］　CHI W，CHEN H，LI F，ZHU Y，YIN W，ZHUO Y.HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-kappaB pathway in acute glaucoma［J］.J Neuroinflammation，2015，12（1）：137.
［41］　CHI W，LI F，CHEN H，WANG Y，ZHU Y，YANG X，et al.Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1beta production in acute glaucoma［J］.Proc Natl Acad Sci USA，2014，111（30）：11181-11186.
［42］　NIU L，ZHANG S，WU J，CHEN L，WANG Y.Upregulation of NLRP3 Inflammasome in the Tears and Ocular Surface of Dry Eye Patients［J］.PLoS One，2015，10（5）：e0126277.
［43］　ZHENG Q，REN Y，REINACH P S，XIAO B，LU H，ZHU Y，et al.Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients［J］.Exp Eye Res，2015，134（5）：133-140.
［44］　DEVI T S，LEE I，HUTTEMANN M，KUMAR A，NANTWI K D，SINGH L P.TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia：implications for diabetic retinopathy［J］.Exp Diabetes Res，2012，2012：438238.
［45］　CHEN W，ZHAO M，ZHAO S，LU Q，NI L，ZOU C，et al.Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy：a novel inhibitory effect of minocycline［J］.Inflamm Res，2017，66（2）：157-166.
［46］　SHI H，ZHANG Z，WANG X，LI R，HOU W，BI W，et al.Inhibition of autophagy induces IL-1beta release from ARPE-19 cells via ROS mediated NLRP3 inflammasome activation under high glucose stress［J］.Biochem Biophys Res Commun，2015，463（4）：1071-1076.
［47］　QI Y，ZHAO M，BAI Y，HUANG L，YU W，BIAN Z，et al.Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes［J］.Invest Ophthalmol Vis Sci，2014，55（9）：5466-5475.
［48］　MALHOTRA S，RIO J，URCELAY E，NURTDINOV R，BUSTAMANTE M F，FERNANDEZ O，et al.NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis［J］.Brain，2015，138（Pt3）：644-652.
［49］　GUARDA G，BRAUN M，STAEHLI F，TARDIVEL A，MATTMANN C，FORSTER I，et al.Type I interferon inhibits interleukin-1 production and inflammasome activation［J］.Immunity，2011，34（2）：213-223.
［50］　COLL R C，ROBERTSON A A，CHAE J J，HIGGINS S C，MUNOZ-PLANILLO R，INSERRA M C，et al.A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases［J］.Nat Med，2015，21（3）：248-255.
［51］　YOUM Y H，NQUVN K Y，GRANT R W，GOLDBERG E L，BODOGAI M，KIM D，et al.The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease［J］.Nat Med，2015，21（3）：263-269.
［52］　CHANG G R，CHEN P L，HOU P H，MAO F C.Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice［J］.Iran J Basic Med Sci，2015，18（11）：1063-1071.
［53］　GUO W，LIU W，JIN B，GENG J，LI J，DING H，et al.Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflam- masome activation［J］.Int Immunopharmacol，2015，24（2）：232-238.

相似文献/References:

[1]李炜炜,马林,苑晓勇.眼表常见警报素的研究进展[J].眼科新进展,2018,38(1):089.[doi:10.13389/j.cnki.rao.2018.0020]
　LI Wei-Wei,MA Lin,YUAN Xiao-Yong.Research advances in alarmins of ocular surface[J].Recent Advances in Ophthalmology,2018,38(9):089.[doi:10.13389/j.cnki.rao.2018.0020]

更新日期/Last Update: 2018-08-31